Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Halozyme Therapeutic (NQ: HALO)
15.85 USD  +0.11 (+0.70%)
Streaming Delayed Price  /  Updated: 12:11 PM EDT, Oct 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 140,778
Open 15.79
Bid (Size) 15.84 (3)
Ask (Size) 15.85 (3)
Prev. Close 15.74
Today's Range 15.76 - 15.98
52wk Range 13.24 - 18.10
Shares Outstanding 143,965,620
Dividend Yield N/A
Performance
YTD
+7.09%
+7.09%
1 Month
-3.06%
-3.06%
3 Month
-5.43%
-5.43%
6 Month
-3.12%
-3.12%
1 Year
-12.19%
-12.19%
Featured News
More News
Volatility Index signals that the bull has room to run
The Volatility Index has yet to reach complacent extremes, suggesting that the U.S. markets’ 2015 rally has room to run. Read More
category Market News , Financial Services , MDY , and 24 more.
from MarketWatch
Ciena Corp. jumps on earnings; PVH sinks
Ciena Corp. is up sharply on earnings while PVH Corp, which owns Calvin Klein, sinks on results. Read More
category Textiles and Apparel , T , Manufacturing , and 20 more.
from MarketWatch
Featured News
Read More
Friday’s biggest gaining and declining stocks
category BAC , Manufacturing , RIMM , and 20 more.
from MarketWatch
Friday’s biggest gaining and declining stocks
category ASTX , WMC , Market News , and 10 more.
from MarketWatch
Thursday's biggest gaining and declining stocks
category SNTS , General , HALO , and 3 more.
from MarketWatch
Drug stocks retreat with broader market
category $BTK , MRK , Company Announcements , and 8 more.
from MarketWatch
More News
Read More
Halozyme To Participate In 2019 Cantor Global Healthcare Conference
from PR Newswire
Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Halozyme's Enhanze® Drug Delivery Technology
from PR Newswire
REPEAT/Halo Announces the Agreement to Acquire a Dispensary Application Software Company and a Concurrent Private Placement
from Business Wire News Releases
Halo Announces the Agreement to Acquire a Dispensary Application Software Company and a Concurrent Private Placement
from Business Wire News Releases
Halozyme To Participate In 2019 Wells Fargo Healthcare Conference
from PR Newswire
Halozyme Reports Second Quarter 2019 Results
from PR Newswire
Halozyme To Participate In 39th Annual Canaccord Genuity Growth Conference
from PR Newswire
Halozyme To Host Second Quarter 2019 Financial Results Webcast And Conference Call
from PR Newswire
FAD's Underlying Holdings Imply 13% Gain Potential
category ETFs
from ETF Channel
REPEAT/Halo Announces the Launch of XES Sensual, a Unique CBD Sexual Wellness Product Continues Company Trend of Product Innovation in Growing Category
from Business Wire News Releases
Halo Announces the Launch of XES Sensual, a Unique CBD Sexual Wellness Product Continues Company Trend of Product Innovation in Growing Category
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

WHAT'S POPULAR IN THE VILLE